Detailed Narrative
Strong Revenue and EBITDA Growth Driven by Acquisitions
Zydus Wellness reported a significant increase in net sales by 113.7% for Q3 FY26, with consolidated EBITDA growing 312.2% to INR610 million. This led to an EBITDA margin expansion to 6.3% from 3.2% in the prior year. The substantial growth was primarily attributed to the full quarter inclusion of the Comfort Click business and strong performance from the Food & Nutrition segment, which grew by 134%.
Gross Margin Expansion and Cost Structure Shift
The company's gross margin jumped to 63% in Q3 FY26, largely due to the higher-margin profile of the newly acquired Comfort Click business. Management clarified that the increased advertisement expenses are a 'new normal' for Comfort Click, as its digital marketing model involves variable, high marketing spends. This indicates a structural shift in the overall cost architecture, rather than a temporary seasonal effect.
Acquisition Performance and Integration
Both Comfort Click and RiteBite Max Protein acquisitions are performing well. Comfort Click is operating in line with expectations and is cash EPS accretive, despite significant interest (INR371 million) and amortization (INR472 million) costs. RiteBite Max Protein has improved its EBITDA from breakeven at acquisition to double-digit margins. The company is actively integrating these businesses, focusing on talent retention through long-term incentives and ensuring smooth operations.
Strategic Focus on Existing Markets and D2C for Comfort Click
For Comfort Click, the primary growth strategy is to deepen penetration in existing European markets, leveraging D2C channels to build long-term customer value. While new markets like Poland, Finland, Portugal, and the US have been entered, they are currently very small. The company is also tracking key KPIs such as repeat purchase rates (above 50% on marketplaces) and brand ratings (above 4.6 out of 5).
Base Business Performance and Long-Term Margin Targets
The base business, excluding Comfort Click and seasonal brands, delivered double-digit growth in YTD FY26. While Q3 base business margins were lower due to the absence of INR90 million GST budgetary support from the prior year and increased investments, management reiterated its long-term target of achieving 16-18% EBITDA margins for the base business within the next 1-2 years. Short-term margin fluctuations are viewed as acceptable for building future growth.
Challenges in Personal Care and Seasonal Brands
The Personal Care segment experienced a 1.4% decline in Q3. Brands like Everyuth and Nycil saw lower performance, attributed to seasonality and trade sentiment, with calendar year 2025 being particularly challenging for Nycil/Glucon-D due to worse-than-usual seasonality impacting trade inventory. Management has taken actions to clean up inventory and expects a recovery in the upcoming season, which typically starts in March-April.
Upcoming Clarifications and Future Outlook
The company's team is actively working to finalize the impact of the recently announced MAT provisions on the tax rate, with information expected to be disseminated within a week. Management also committed to improving segmental disclosures by the end of the year to provide better visibility on its increasingly complex portfolio. From next financial year onwards, the company expects to be EPS accretive at the PAT level, even for the newly acquired entities.